Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 539938 | NSE Symbol : | ISIN : INE858Q01019 | Industry : Trading |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
22-Apr-2025	22-Apr-2025	Change in Other Executives	With reference to the subject captioned above, in compliance of the Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Ms. Puneeta Sharma, Company Secretary & Compliance Officer of the Company has tendered her resignation from the post of Company Secretary & Compliance Officer of the Company w.e.f. 22nd April, 2025, due to personal reasons. She is relieved on 22nd April, 2025 after the close of normal business hours of the Company. The additional details regarding the same is attached as Annexure - A. Please find enclosed herewith Resignation Letter submitted by Ms. Puneeta Sharma. You are requested to take the same on record. The Board Meeting of the Company commenced at 05:30 PM and concluded at 06:30 PM.
07-Apr-2025	07-Apr-2025	Investments	Outcome of Board meeting
06-Feb-2025	14-Feb-2025	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December 2024 and any other business items as per agenda circulated. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2025, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, along with Limited Review Report' for the quarter and nine months ended on December 31, 2024 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:50 PM. Results - Quarter and Nine Months ended December 31, 2024 (As Per BSE Announcement Dated on 14.02.2025)
06-Nov-2024	14-Nov-2024	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Intimation of Board Meeting for the unaudited financial results for the quarter and half year ended 30th September 2024. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2024, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, Statement of Assets and Liabilities and Cash Flow Statement along with Limited Review Report' for the quarter and half year ended on September 30, 2024 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com. The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:50 PM. (As Per Bse Announcement Dated on 14.11.2024)
28-Sep-2024	27-Sep-2024	Change in Auditors	Disclosure in compliance of Regulation 30 of SEBI LODR, 2015.
06-Aug-2024	13-Aug-2024	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June 2024 and any other business items as per agenda circulated. Outcome of Board meeting held on 13.08.2024 and Compliances of Regulation 30, 33 and 42 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 13.08.2024)
18-May-2024	25-May-2024	Accounts	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March 2024 any other business items as per the agenda circulated. Pursuant to provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 25, 2024, based on the recommendations of Audit Committee, inter alia, considered and approved agenda as per the attached pdf. The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:30 PM. (As Per BSE Announcement Dated on 25.05.2024)
30-Apr-2024	10-May-2024	Postal Ballot	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2024 inter alia to consider and approve We wish to inform you that the Meeting of Board of Directors of the Company scheduled to be held on Tuesday 7th May 2024 inter alia to consider and approve the Notice of Postal Ballot and any other business items as per agenda circulated. The Board Meeting to be held on 07/05/2024 has been revised to 10/05/2024 The Board Meeting to be held on 07/05/2024 has been revised to 10/05/2024 (As Per BSE Announcement Dated on 06.05.2024) Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, read together with the circulars and notification issued thereunder ('Listing Regulations') and in continuation of our intimation dated 30th April, 2024 and revised intimation dated 6th May, 2024, The Board, at their meeting held today i.e., Friday, May 10, 2024, based on the recommendations of Audit Committee and Nomination and Remuneration Committee, inter alia, considered and approved the business as mentioned in the attached file and approved the notice of postal ballot Board of Directors approved Notice of Postal Ballot in their meeting held today 10th May, 2024. (As Per BSE Announcement dated on 10.05.2024)
09-Apr-2024	09-Apr-2024	Investments	Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., April 09, 2024, inter alia, considered and approved investing Company funds by way of infusing initial capital of Rs. 50,000/- i.e., holds 50% stake in proposed partnership firm having the same business segment i.e., pharmaceutical segment. Outcome of Board Meeting and Compliances of Regulation 30 of SEBI LODR, 2015.
06-Feb-2024	14-Feb-2024	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve The meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 14th February 2024 at the registered office of the Company situated at 1-5th Floor Aditraj Arcade Nr Karma Shreshtha Tower 100 Ft Rd Satellite Ahmedabad Gujarat - 380015 to inter alia consider approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December 2023 and any other business items as per agenda circulated. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2024, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2023 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results along with Limited Review Report' for the quarter and nine months ended on December 31, 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com. The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:55 PM. Results - Financials for the Quarter and nine months ended 31/12/2023 (As Per BSE Announcement Dated on 14/02/2024)
31-Oct-2023	08-Nov-2023	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve The unaudited Financial Results (Standalone and Consolidated) Statement of Assets and Liabilities and Cash Flow Statement for quarter and half year ended 30th September 2023 and any other business items as per agenda circulated. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 08, 2023, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on September 30, 2023 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, Statement of Assets and Liabilities and Cash Flow Statement along with Limited Review Report' for the quarter ended on September 30, 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 03:30 PM and concluded at 04:40 PM. Financial Results for the Quarter ended 30 September 2023. (As Per BSE Announcement Dated on 08/11/2023)
07-Aug-2023	14-Aug-2023	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June 2023 and any other business items as per agenda circulated. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., August 14, 2023, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2023 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results along with Limited Review Report' for the quarter ended on June 30, 2023 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:35 PM. (As Per BSE Announcement Dated on 14.08.2023)
22-May-2023	29-May-2023	Accounts	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March 2023 and Recommend dividend if any for the financial year ended 31st March 2023 and any other business items as per agenda circulated. Further in continuation of our earlier intimation dated March 31 2023 in compliance of the provisions of the SEBI (Prohibition of Insider Trading) Regulations and in pursuant to Companies Code of Conduct for prevention of Insider Trading in Shares of the Company the Trading window for dealing in the securities of the Company for all the designated persons including insiders has already been closed w.e.f 31st March 2023 and the same shall be closed till the conclusion of 48 hours after the declaration of financial results of the company for the quarter and year ended March 31 2023. Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 29, 2023, based on the recommendations of Audit Committee and Nomination and Remuneration Committee, inter alia, considered and approved various items as per attached file Reappointment of Managing Directors and Independent Director of the Company. Reappointment of Managing Director and Independent Director of the Company. Board Recommended a final dividend of Rs. 0.10/- per equity share of the face value of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval by the shareholders at their 39th Annual General Meeting. The Dividend, if approved by the Shareholders will be paid on or after 5th July, 2023. The Record Date has been fixed as Friday, June 23, 2023 to determine the list of members entitled to receive the Final Dividend for the financial year 2022-23, recommended by the Board of Directors subject to the approval of the same by the members at the ensuing Annual General Meeting. We are pleased to inform you that the meeting of Board of Directors was held on 29th May, 2023, wherein the Board decided to convene the Annual General Meeting of the Company on Friday, 30th June, 2023 at 12:00 P.M. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, please be informed that the Register of Transfer and Register of Members of the Company shall remain closed as per the dates mentioned in the attached file for the purpose of conducting AGM. Pursuant to provisions of Regulation 30, 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 29, 2023, based on the recommendations of Audit Committee and Nomination and Remuneration Committee, inter alia, considered and approved various items as per attached file Reappointment of Managing Directors and Independent Director of the Company. (As Per BSE Announcement Dated on 29.05.2023)
07-Feb-2023	14-Feb-2023	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve With reference to the captioned subject we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 14th February 2023 at the registered office of the Company situated at 1-5th Floor Aditraj Arcade Nr Karma Shreshtha Tower 100 Ft Rd Satellite Ahmedabad Gujarat - 380015 to inter alia consider approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December 2022 and any other business items as per agenda circulated. Pursuant to provisions of Regulation 30 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2023, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2022 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Unaudited Standalone and Consolidated Financial Results along with Limited Review Report' for the quarter and nine months ended on December 31, 2022 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:30 PM. (As per BSE Announcement Dated on 14/02/2023) We hereby wish to inform you that the unaudited financial results (Standalone & Consolidated) for the quarter and nine months ended 31st December, 2022 were approved at the meeting of Board of Directors held on Tuesday, 14th February, 2023. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith. (As Per BSE Announcement dated on 15.02.2023)
07-Nov-2022	14-Nov-2022	Quarterly Results	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve With reference to the captioned subject we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday 14th November 2022 at the registered office of the Company situated at 1-5th Floor Aditraj Arcade Nr Karma Shreshtha Tower 100 Ft Rd Satellite Ahmedabad Gujarat - 380015 to inter alia consider approve and take on record the unaudited Financial Results (Standalone and Consolidated) along with Statement of Assets and Liabilities and Cash Flow Statement for quarter and half year ended 30th September 2022 and any other business items as per agenda circulated. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2022, inter alia, considered and approved as per the attached PDF. Further, please find enclosed 'Unaudited Standalone and Consolidated Financial Results along with Limited Review Report, Statement of Assets and Liabilities and Cash Flow Statement' for the quarter and half year ended on September 30, 2022 as Annexure 1, the details required under SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated 9th September, 2015 is provided as Annexure 2 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 03:30 PM and concluded at 05:25 PM. Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2022, inter alia, considered and approved as per attached PDF. Further, please find enclosed 'Unaudited Standalone and Consolidated Financial Results along with Limited Review Report, Statement of Assets and Liabilities and Cash Flow Statement' for the quarter and half year ended on September 30, 2022 as Annexure 1, the details required under SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated 9th September, 2015 is provided as Annexure 2 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 03:30 PM and concluded at 05:25 PM. (As Per BSE Announcement Dated on 14.11.2022) We hereby wish to inform you that the unaudited financial results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2022 were approved at the meeting of Board of Directors held on Monday, 14th November, 2022. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith. (As per BSE Announcement Dated on 15/11/2022)

1 2

LOGIN HERE

Medico Intercontinental Ltd

Board Meeting